These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 12414630

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Silica-induced activation of c-Jun-NH2-terminal amino kinases, protracted expression of the activator protein-1 proto-oncogene, fra-1, and S-phase alterations are mediated via oxidative stress.
    Shukla A, Timblin CR, Hubbard AK, Bravman J, Mossman BT.
    Cancer Res; 2001 Mar 01; 61(5):1791-5. PubMed ID: 11280724
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Expression of dominant negative Erk2 inhibits AP-1 transactivation and neoplastic transformation.
    Watts RG, Huang C, Young MR, Li JJ, Dong Z, Pennie WD, Colburn NH.
    Oncogene; 1998 Dec 31; 17(26):3493-8. PubMed ID: 10030673
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Mitogen activated protein kinase-dependent activation of c-Jun and c-Fos is required for neuronal differentiation but not for growth and stress response in PC12 cells.
    Eriksson M, Taskinen M, Leppä S.
    J Cell Physiol; 2007 Feb 31; 210(2):538-48. PubMed ID: 17111371
    [Abstract] [Full Text] [Related]

  • 8. Phosphorylation and high level expression of Fra-2 in v-src transformed cells: a pathway of activation of endogenous AP-1.
    Murakami M, Sonobe MH, Ui M, Kabuyama Y, Watanabe H, Wada T, Handa H, Iba H.
    Oncogene; 1997 May 22; 14(20):2435-44. PubMed ID: 9188858
    [Abstract] [Full Text] [Related]

  • 9. Age-related differences in MAP kinase activity in VSMC in response to glucose or TNF-alpha.
    Li M, Mossman BT, Kolpa E, Timblin CR, Shukla A, Taatjes DJ, Fukagawa NK.
    J Cell Physiol; 2003 Dec 22; 197(3):418-25. PubMed ID: 14566971
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. AP-1 regulates alpha2beta1 integrin expression by ERK-dependent signals during megakaryocytic differentiation of K562 cells.
    Eriksson M, Arminen L, Karjalainen-Lindsberg ML, Leppä S.
    Exp Cell Res; 2005 Mar 10; 304(1):175-86. PubMed ID: 15707584
    [Abstract] [Full Text] [Related]

  • 12. PACAP and C2-ceramide generate different AP-1 complexes through a MAP-kinase-dependent pathway: involvement of c-Fos in PACAP-induced Bcl-2 expression.
    Aubert N, Falluel-Morel A, Vaudry D, Xifro X, Rodriguez-Alvarez J, Fisch C, de Jouffrey S, Lebigot JF, Fournier A, Vaudry H, Gonzalez BJ.
    J Neurochem; 2006 Nov 10; 99(4):1237-50. PubMed ID: 17026529
    [Abstract] [Full Text] [Related]

  • 13. Microarray analysis and RNA silencing link fra-1 to cd44 and c-met expression in mesothelioma.
    Ramos-Nino ME, Scapoli L, Martinelli M, Land S, Mossman BT.
    Cancer Res; 2003 Jul 01; 63(13):3539-45. PubMed ID: 12839939
    [Abstract] [Full Text] [Related]

  • 14. Transition from SCLC to NSCLC phenotype is accompanied by an increased TRE-binding activity and recruitment of specific AP-1 proteins.
    Risse-Hackl G, Adamkiewicz J, Wimmel A, Schuermann M.
    Oncogene; 1998 Jun 11; 16(23):3057-68. PubMed ID: 9662339
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Dual role for mitogen-activated protein kinase (Erk) in insulin-dependent regulation of Fra-1 (fos-related antigen-1) transcription and phosphorylation.
    Hurd TW, Culbert AA, Webster KJ, Tavaré JM.
    Biochem J; 2002 Dec 01; 368(Pt 2):573-80. PubMed ID: 12197835
    [Abstract] [Full Text] [Related]

  • 17. The gamma-glutamylcysteine synthetase and glutathione regulate asbestos-induced expression of activator protein-1 family members and activity.
    Shukla A, Flanders T, Lounsbury KM, Mossman BT.
    Cancer Res; 2004 Nov 01; 64(21):7780-6. PubMed ID: 15520183
    [Abstract] [Full Text] [Related]

  • 18. Mechanism of AP-1-mediated gene expression by select organochlorines through the p38 MAPK pathway.
    Frigo DE, Tang Y, Beckman BS, Scandurro AB, Alam J, Burow ME, McLachlan JA.
    Carcinogenesis; 2004 Feb 01; 25(2):249-61. PubMed ID: 14604893
    [Abstract] [Full Text] [Related]

  • 19. Celecoxib inhibits phorbol ester-induced expression of COX-2 and activation of AP-1 and p38 MAP kinase in mouse skin.
    Chun KS, Kim SH, Song YS, Surh YJ.
    Carcinogenesis; 2004 May 01; 25(5):713-22. PubMed ID: 14729583
    [Abstract] [Full Text] [Related]

  • 20. AP-1 transrepressing retinoic acid does not deplete coactivators or AP-1 monomers but may target specific Jun or Fos containing dimers.
    Suzukawa K, Colburn NH.
    Oncogene; 2002 Mar 28; 21(14):2181-90. PubMed ID: 11948401
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.